ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs MXN
16.87825
-0.04%
Brent Oil
82.905
-0.68%
Bitcoin
64,032.34
1.37%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Century Therapeutics Inc (IPSC)

  7. Century Therapeutics Inc (IPSC) Noticias

IPSC

Century Therapeutics (IPSC)

Century Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IPSC
FechaHoraFuenteTítuloSímboloCompañía
06/05/202415:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
23/04/202406:00GlobeNewswire Inc.Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:IPSCCentury Therapeutics Inc
11/04/202406:00GlobeNewswire Inc.Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade TherapeuticsNASDAQ:IPSCCentury Therapeutics Inc
08/04/202415:05GlobeNewswire Inc.Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
25/03/202406:00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:IPSCCentury Therapeutics Inc
19/03/202406:00GlobeNewswire Inc.Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:IPSCCentury Therapeutics Inc
14/03/202406:30GlobeNewswire Inc.Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
08/03/202417:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
05/03/202417:03GlobeNewswire Inc.Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
21/02/202412:04Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IPSCCentury Therapeutics Inc
01/02/202406:00GlobeNewswire Inc.Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IPSCCentury Therapeutics Inc
19/01/202416:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
09/12/202311:00GlobeNewswire Inc.Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ EditsNASDAQ:IPSCCentury Therapeutics Inc
06/12/202315:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/12/202306:30GlobeNewswire Inc.Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus ErythematosusNASDAQ:IPSCCentury Therapeutics Inc
06/12/202306:30GlobeNewswire Inc.Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus ErythematosusNASDAQ:IPSCCentury Therapeutics Inc
21/11/202306:00GlobeNewswire Inc.Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:IPSCCentury Therapeutics Inc
09/11/202306:01GlobeNewswire Inc.Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
09/11/202306:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IPSCCentury Therapeutics Inc
09/11/202306:00GlobeNewswire Inc.Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory DiseasesNASDAQ:IPSCCentury Therapeutics Inc
09/11/202306:00GlobeNewswire Inc.Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive OfficerNASDAQ:IPSCCentury Therapeutics Inc
02/11/202308:00GlobeNewswire Inc.Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits at the 65th ASH Annual Meeting and ExpositionNASDAQ:IPSCCentury Therapeutics Inc
26/09/202306:00GlobeNewswire Inc.Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines ConferenceNASDAQ:IPSCCentury Therapeutics Inc
09/08/202306:30GlobeNewswire Inc.Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
29/06/202315:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IPSCCentury Therapeutics Inc
11/05/202306:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IPSCCentury Therapeutics Inc
11/05/202306:30GlobeNewswire Inc.Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
05/05/202315:46Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IPSCCentury Therapeutics Inc
05/05/202315:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IPSCCentury Therapeutics Inc
28/04/202315:11Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:IPSCCentury Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:IPSC

Su Consulta Reciente

AMEX
XLV
Health Care Select Sector
NASDAQ
NVDA
NVIDIA
CCOM
US500
US 500
NASDAQ
GOOGL
Alphabet
CCOM
SILVER
SILVER
USOTC
ADDYY
Adidas (QX)
SPI
SP500
S&P 500
CCOM
OILBRENT
Brent Oil
NYSE
XOM
Exxon Mobil
FX
EURMXN
Euro vs MXN
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
USI
USTECH100
US Tech 100
CCOM
US30
US 30
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados